Shanghai Issues Regulations to Promote the Development of Artificial Intelligence Industry, What's the Impact on the Healthcare Sector?

Shanghai Regulations on Promoting the Development of Artificial Intelligence Industry came into effect on October 1, 2022, which is the country's first provincial-level local regulation to promote the development of artificial intelligence industry, and will help Shanghai build an AI industry system with open ecological integration, active innovation clusters, ubiquitous super scenarios, and agile governance and security, and build an internationally influential AI "Shanghai Highland".

The Regulations make it clear that it is necessary to promote the construction of high-quality data sets in the field of artificial intelligence. Support the relevant subjects to integrate data with industry knowledge in depth, develop data products to serve the needs of algorithm design, model training, product validation, scene application and so on. Encourage relevant subjects to carry out collaborative research and development of big data and artificial intelligence technology, develop professional tools and series of standards for data labeling, build big data labs for artificial intelligence training, and construct large-scale artificial intelligence data resource libraries.

Relying on the public **** data opening mechanism, establish a dynamic open list of public **** data in the fields of economic development, people's livelihood services, urban governance, etc., and promote the categorized, graded and orderly openness of public **** data in the fields of life and health, automated driving, etc., and expand the scope of the supply of public **** data for the AI industry.

The medical-related content is as follows:

In the "Industrial Development" section, it is mentioned to support the relevant subjects to carry out research and development of key technologies for AI medical devices, and to strengthen the breakthroughs in the areas of intelligent assisted diagnostic algorithms, surgical localization navigation, and fusion of brain-computer interfaces, etc.; to strengthen the registration and approval of AI medical devices, and to provide relevant guidance services, and to support relevant innovative products. The company will provide guidance services and support related innovative products to enter the national innovative medical device special approval process; support the exploration of qualified artificial intelligence medical devices in clinical applications in the charging mode.

In the "Application Enablement" section, it is mentioned to promote the application innovation of AI in the medical field, build intelligent medical infrastructure, establish a new model of AI-enabled medical services, enhance the innovation capacity of medical technology, and promote the intelligent transformation of the medical field; support medical institutions, enterprises and other applications, develop intelligent medical systems that collaborate with humans and machines, and encourage the development of flexible and flexible medical devices. medical system, encourage the development of flexible wearable, biocompatible intelligent physiological monitoring system.